In round 3 of the impact purchase, $2600 of certificates were purchased from sellers (and $700 of certificates were repurchased from the impact purchase organizers). Thanks to Larks and Owen Cotton-Barratt, who also purchased certificates this round.
The deadline for round 4 is June 25. If you are interested in selling, apply here (any kind of submission is welcome, and you are free to opt out of public scrutiny). If you have questions, feel free to get in touch or leave a comment here.
The transactions:
- We purchased another 1/70th of Ryan Carey and Brayden McLean's organization of EA Melbourne for $1700 (a price of $119k for the whole thing, significantly higher than in the last round). This money was our $1000 budget plus the $700 we received by reselling old certificates.
- Larks purchased 9.9% of Oliver Habryka's organization of wrap parties, paying us $300 and Oliver $700 (a price of around $10k, somewhat less than we paid)
- Owen purchased 1/3 of Ben Kuhn's donation matching blog post from us for $400 (a price of $1.2k, exactly what we originally paid)
- Owen purchased 0.4% of EA Melbourne for $200 (a price of $50k, much less than what we are paying)
We're going to experiment with starting a comment thread here for each project that was submitted to the impact purchase (where we had permission to start a thread). We'll use these threads to keep track of transactions, and to discuss our evaluations. We invite discussion of the projects, criticism of the evaluations and our decisions, offers to purchase certificates or sell similar certificates, questions, etc.
If you might be interested in purchasing certificates, please send us an email or leave a comment. We can't really make money (our counterparties always receive all of the gains from trade), but we'd love to see a more liquid market for impact in general.
Submission: Joao Fabiano's research comparing caffeine and modafinil. His description:
"I did a literature review, cost-benefit analysis, ethical assessment and produced a dissertation, blog posts and gave several talks about it. Most of the research was done at the beginning of 2014 as part of my MPhil dissertation (available here in Portuguese, there's an English abstract on page 5). That research spawned many blog posts and presentations in and outside academia, in Brazil and in the UK. Some of these blog posts are available in English here: one, two, three"
Our very crude evaluation:
We had a hard time estimating the total impact of this research. It laid out an interesting case that modafinil is a reasonable alternative to caffeine, at least setting aside social factors. It did not seem to credibly address the main empirical questions that would motivate us to adopt either modafinil or caffeine, and we expect that most readers would be similarly skeptical (if they were sufficiently open-minded to plausibly take modafinil on the basis of analysis). We thought about evaluation by considering how hard it would be to produce a similar amount of value by paying for empirical research or critical review that would help clarify the benefits of modafinil and potentially push adoption.